CAM
MNTA

Cresset Asset Management’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Cresset Asset Management’s Portfolio MNTA Stock Details MNTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-111
Closed -$2K – 1991
2019
Q1 		$2K Buy
+111
New +$1.42K ﹤0.01% 1731

Other funds holding MNTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Cresset Asset Management's MNTA Position: Q2 2019 in Review

Cresset Asset Management sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q2 2019, closing a stake of 111 shares — an estimated $2K sold.

Cresset Asset Management first reported a position in MNTA in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 155 funds tracked by Wall St. Rank hold MNTA as of Q2 2019.

  • Cresset Asset Management reported no remaining Momenta Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
  • Cresset Asset Management sold 111 Momenta Pharmaceuticals, Inc. shares in Q2 2019, an estimated $2K.
  • Cresset Asset Management first reported a position in Momenta Pharmaceuticals, Inc. in Q1 2019 and held it in 1 quarter.
  • Cresset Asset Management's Momenta Pharmaceuticals, Inc. position peaked at $2K in Q1 2019.
  • 155 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q2 2019.

Based on Cresset Asset Management's 13F filing for Q2 2019, filed 12 Aug 2019.